Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder
| Status: | Completed |
|---|---|
| Conditions: | Depression, Major Depression Disorder (MDD), Neurology, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | September 2011 |
| End Date: | December 2014 |
Measuring Adherence to Standard-of-Care Medication for Depression and ADHD in a College Student Population
Poor adherence is a common reason for treatment failure in many fields of medicine, and
likely affects common psychiatric treatments as well. Members of the present study team have
used Medication Event Monitoring System (MEMS®) caps effectively to objectively monitor
adherence in skin disease, and have shown that they provide a much more accurate measure of
adherence behavior than self-reports, pill counts, or serum drug concentrations. The present
study will use MEMS® caps to measure adherence in 10 patients with depression and 10
patients with attention-deficit hyperactivity disorder (ADHD) from a student clinic
population. The aims will be to show the usefulness of MEMS® caps in measuring adherence to
psychiatric treatment, and gather data on typical adherence rates for depression and ADHD
patients on typical treatment regimens. The data obtained will be used to inform future
studies that use an intervention to improve adherence behavior and ultimately disease
outcomes.
likely affects common psychiatric treatments as well. Members of the present study team have
used Medication Event Monitoring System (MEMS®) caps effectively to objectively monitor
adherence in skin disease, and have shown that they provide a much more accurate measure of
adherence behavior than self-reports, pill counts, or serum drug concentrations. The present
study will use MEMS® caps to measure adherence in 10 patients with depression and 10
patients with attention-deficit hyperactivity disorder (ADHD) from a student clinic
population. The aims will be to show the usefulness of MEMS® caps in measuring adherence to
psychiatric treatment, and gather data on typical adherence rates for depression and ADHD
patients on typical treatment regimens. The data obtained will be used to inform future
studies that use an intervention to improve adherence behavior and ultimately disease
outcomes.
Inclusion Criteria:
- Any male or female, at least 18 years of age, using the Student Health Clinic, with a
diagnosis of depression or ADHD.
- Written consent of participation must be given by the subject.
Exclusion Criteria:
- Subject is less than 18 years of age.
- Inability to complete all study-related visits.
- Introduction of any other prescription medication while participating in the study.
(Patients who are on a stable dose of non-study-related prescription medications for
at least 4 weeks prior to the study, and throughout the study period, are not
excluded.)
- Female patients whose medications may be harmful during pregnancy must be on an
acceptable form of birth control, otherwise they will not be eligible for
participation.
We found this trial at
1
site
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
Winston-Salem, North Carolina 27157
336-716-2011
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
Click here to add this to my saved trials
